California Officially Approves Third-Party Lasix Rules; Implementation Expected Late this Year: Paulick Report 6/3/17

By: Press Release The State of California has officially approved rules establishing that race-day medication must be administered by independent veterinary professionals – further aligning California with the national uniform medication program. The California Office of Administrative Law advised the California Horse Racing Board on Thursday that amendments to CHRB Rules 1433 and 1845, which

EIPH Research a Fundraising Priority for AAEP Foundation: AAEP 8/22/16

By: AAEP News Room The AAEP Foundation, the charitable arm of the American Association of Equine Practitioners (AAEP), today announced its designation of exercise-induced pulmonary hemorrhage (EIPH) research as a fundraising priority. EIPH refers to the presence of blood in the airways of a horse’s lung during exercise. The condition is commonly reported in racehorses

Studies on Lasix Administration Progressing:Blood-Horse 3/23/16

By: Frank Angst In a presentation at the Association of Racing Commissioners International conference March 23 in New Orleans, Jockey Club executive director Matt Iuliano highlighted studies examining the efficacy of administering furosemide at least 24 hours before a race. RCI president Ed Martin noted that some conference presentations will allow member commissioners to see

AAEP Panel Examines Possible Research Paths for EIPH Treatment: AAEP

As part of its strategic initiative to protect the health and welfare of the racehorse, the American Association of Equine Practitioners has released a list of research topics identified by an expert panel as central to the goal of understanding exercise-induced pulmonary hemorrhage. The identified topics will help determine future research priorities in the investigation

Foundation Authorizes Two Lasix Studies: The Blood-Horse 9/15/15

By Blood-Horse Staff Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15. The studies will examine the pathophysiology of EIPH, or bleeding in horses' lungs. The condition is currently treated with furosemide, also known

Racing Medication and Testing Consortium to Hold Special Board Meeting August 4 7/13/11

NEWS RELEASE July 13, 2011 Contact: Rebecca A. Hills (859) 224-2844 RACING MEDICATION AND TESTING CONSORTIUM TO HOLD SPECIAL BOARD MEETING AUGUST 4 The Racing Medication and Testing Consortium (RMTC), which consists of 25 racing industry stakeholders and organizations that represent Thoroughbred, Standardbred, American Quarter Horse and Arabian racing, will hold a special meeting of